Technology
Health
Biotechnology

Zafgen

$2.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (0.76%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Zafgen and other stocks, options, ETFs, and crypto commission-free!

About

Zafgen, Inc. Common Stock, also called Zafgen, is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. Read More It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA.

Employees
38
Headquarters
Boston, Massachusetts
Founded
2005
Market Cap
99.28M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
326.18K
High Today
$2.83
Low Today
$2.64
Open Price
$2.65
Volume
85.18K
52 Week High
$12.36
52 Week Low
$2.33

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2014 IPO
US
North America

News

Yahoo FinanceMay 9

Zafgen: 1Q Earnings Snapshot

BOSTON (AP) _ Zafgen Inc. (ZFGN) on Thursday reported a loss of $13.1 million in its first quarter. The Boston-based company said it had a loss of 35 cents per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share. In the final minutes of trading on Thursday, the company's shares hit $2.61. A year ago, they were trading at $6.50. _____ This story was generated by Automated Insights (http://...

55
Simply Wall StApr 26

Did Changing Sentiment Drive Zafgen’s (NASDAQ:ZFGN) Share Price Down A Worrying 62%?

Even the best stock pickers will make plenty of bad investments. And there’s no doubt that Zafgen, Inc. (NASDAQ:ZFGN) stock has had a really bad year. In that relatively short period, the share price has plunged 62%. To make matters worse, the returns over three years have also been really disappointing (the share price is 60% lower than three years ago). Furthermore, it’s down 43% in about a quarter. That’s not much fun for holders. Check out our latest analysis for Zafgen Zafgen hasn’t yet reported any ...

112

Earnings

-$0.59
-$0.51
-$0.43
-$0.35
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.